Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carolyn Coffey is active.

Publication


Featured researches published by Carolyn Coffey.


The Lancet | 2009

Global patterns of mortality in young people: a systematic analysis of population health data

George C Patton; Carolyn Coffey; Susan M Sawyer; Russell M. Viner; Dagmar M. Haller; Krishna Bose; Theo Vos; Jane Ferguson; Colin Mathers

BACKGROUND Pronounced changes in patterns of health take place in adolescence and young adulthood, but the effects on mortality patterns worldwide have not been reported. We analysed worldwide rates and patterns of mortality between early adolescence and young adulthood. METHODS We obtained data from the 2004 Global Burden of Disease Study, and used all-cause mortality estimates developed for the 2006 World Health Report, with adjustments for revisions in death from HIV/AIDS and from war and natural disasters. Data for cause of death were derived from national vital registration when available; for other countries we used sample registration data, verbal autopsy, and disease surveillance data to model causes of death. Worldwide rates and patterns of mortality were investigated by WHO region, income status, and cause in age-groups of 10-14 years, 15-19 years, and 20-24 years. FINDINGS 2.6 million deaths occurred in people aged 10-24 years in 2004. 2.56 million (97%) of these deaths were in low-income and middle-income countries, and almost two thirds (1.67 million) were in sub-Saharan Africa and southeast Asia. Pronounced rises in mortality rates were recorded from early adolescence (10-14 years) to young adulthood (20-24 years), but reasons varied by region and sex. Maternal conditions were a leading cause of female deaths at 15%. HIV/AIDS and tuberculosis contributed to 11% of deaths. Traffic accidents were the largest cause and accounted for 14% of male and 5% of female deaths. Other prominent causes included violence (12% of male deaths) and suicide (6% of all deaths). INTERPRETATION Present global priorities for adolescent health policy, which focus on HIV/AIDS and maternal mortality, are an important but insufficient response to prevent mortality in an age-group in which more than two in five deaths are due to intentional and unintentional injuries. FUNDING WHO and National Health and Medical Research Council.


BMJ | 2002

Cannabis use and mental health in young people: cohort study

George C Patton; Carolyn Coffey; John B. Carlin; Louisa Degenhardt; Michael T. Lynskey; Wayne Hall

Abstract Objective: To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood. Design: Seven wave cohort study over six years. Setting: 44 schools in the Australian state of Victoria. Participants: A statewide secondary school sample of 1601 students aged 14-15 followed for seven years. Main outcome measure: Interview measure of depression and anxiety (revised clinical interview schedule) at wave 7. Results: Some 60% of participants had used cannabis by the age of 20; 7% were daily users at that point. Daily use in young women was associated with an over fivefold increase in the odds of reporting a state of depression and anxiety after adjustment for intercurrent use of other substances (odds ratio 5.6, 95% confidence interval 2.6 to 12). Weekly or more frequent cannabis use in teenagers predicted an approximately twofold increase in risk for later depression and anxiety (1.9, 1.1 to 3.3) after adjustment for potential baseline confounders. In contrast, depression and anxiety in teenagers predicted neither later weekly nor daily cannabis use. Conclusions: Frequent cannabis use in teenage girls predicts later depression and anxiety, with daily users carrying the highest risk. Given recent increasing levels of cannabis use, measures to reduce frequent and heavy recreational use seem warranted. What is already known on this topic Frequent recreational use of cannabis has been linked to high rates of depression and anxiety in cross sectional surveys and studies of long term users Why cannabis users have higher rates of depression and anxiety is uncertain Previous longitudinal studies of cannabis use in youth have not analysed associations with frequent cannabis use What this study adds A strong association between daily use of cannabis and depression and anxiety in young women persists after adjustment for intercurrent use of other substances Frequent cannabis use in teenage girls predicts later higher rates of depression and anxiety Depression and anxiety in teenagers do not predict later cannabis use; self medication is therefore unlikely to be the reason for the association


BMJ | 2002

Cannabis use and mental health in younger people: Cohort study.

George C Patton; Carolyn Coffey; John B. Carlin; Louisa Degenhardt; Michael T. Lynskey; Wayne Hall

Abstract Objective: To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood. Design: Seven wave cohort study over six years. Setting: 44 schools in the Australian state of Victoria. Participants: A statewide secondary school sample of 1601 students aged 14-15 followed for seven years. Main outcome measure: Interview measure of depression and anxiety (revised clinical interview schedule) at wave 7. Results: Some 60% of participants had used cannabis by the age of 20; 7% were daily users at that point. Daily use in young women was associated with an over fivefold increase in the odds of reporting a state of depression and anxiety after adjustment for intercurrent use of other substances (odds ratio 5.6, 95% confidence interval 2.6 to 12). Weekly or more frequent cannabis use in teenagers predicted an approximately twofold increase in risk for later depression and anxiety (1.9, 1.1 to 3.3) after adjustment for potential baseline confounders. In contrast, depression and anxiety in teenagers predicted neither later weekly nor daily cannabis use. Conclusions: Frequent cannabis use in teenage girls predicts later depression and anxiety, with daily users carrying the highest risk. Given recent increasing levels of cannabis use, measures to reduce frequent and heavy recreational use seem warranted. What is already known on this topic Frequent recreational use of cannabis has been linked to high rates of depression and anxiety in cross sectional surveys and studies of long term users Why cannabis users have higher rates of depression and anxiety is uncertain Previous longitudinal studies of cannabis use in youth have not analysed associations with frequent cannabis use What this study adds A strong association between daily use of cannabis and depression and anxiety in young women persists after adjustment for intercurrent use of other substances Frequent cannabis use in teenage girls predicts later higher rates of depression and anxiety Depression and anxiety in teenagers do not predict later cannabis use; self medication is therefore unlikely to be the reason for the association


The Lancet | 2012

Health of the world's adolescents: a synthesis of internationally comparable data

George C Patton; Carolyn Coffey; Claudia Cappa; Dorothy Currie; Leanne Riley; Fiona Gore; Louisa Degenhardt; Dominic Richardson; Nan Marie Astone; Adesola Sangowawa; Ali H. Mokdad; Jane Ferguson

Adolescence and young adulthood offer opportunities for health gains both through prevention and early clinical intervention. Yet development of health information systems to support this work has been weak and so far lagged behind those for early childhood and adulthood. With falls in the number of deaths in earlier childhood in many countries and a shifting emphasis to non-communicable disease risks, injuries, and mental health, there are good reasons to assess the present sources of health information for young people. We derive indicators from the conceptual framework for the Series on adolescent health and assess the available data to describe them. We selected indicators for their public health importance and their coverage of major health outcomes in young people, health risk behaviours and states, risk and protective factors, social role transitions relevant to health, and health service inputs. We then specify definitions that maximise international comparability. Even with this optimisation of data usage, only seven of the 25 indicators, covered at least 50% of the worlds adolescents. The worst adolescent health profiles are in sub-Saharan Africa, with persisting high mortality from maternal and infectious causes. Risks for non-communicable diseases are spreading rapidly, with the highest rates of tobacco use and overweight, and lowest rates of physical activity, predominantly in adolescents living in low-income and middle-income countries. Even for present global health agendas, such as HIV infection and maternal mortality, data sources are incomplete for adolescents. We propose a series of steps that include better coordination and use of data collected across countries, greater harmonisation of school-based surveys, further development of strategies for socially marginalised youth, targeted research into the validity and use of these health indicators, advocating for adolescent-health information within new global health initiatives, and a recommendation that every country produce a regular report on the health of its adolescents.


The Lancet | 2012

The natural history of self-harm from adolescence to young adulthood: a population-based cohort study

Paul Moran; Carolyn Coffey; Helena Romaniuk; Craig A. Olsson; Rohan Borschmann; John B. Carlin; George C Patton

BACKGROUND Knowledge about the natural history of self-harm is scarce, especially during the transition from adolescence to young adulthood, a period characterised by a sharp rise in self-inflicted deaths. From a repeated measures cohort of a representative sample, we describe the course of self-harm from middle adolescence to young adulthood. METHODS A stratified, random sample of 1943 adolescents was recruited from 44 schools across the state of Victoria, Australia, between August, 1992, and January, 2008. We obtained data pertaining to self-harm from questionnaires and telephone interviews at seven waves of follow-up, commencing at mean age 15·9 years (SD 0·49) and ending at mean age 29·0 years (SD 0·59). Summary adolescent measures (waves three to six) were obtained for cannabis use, cigarette smoking, high-risk alcohol use, depression and anxiety, antisocial behaviour and parental separation or divorce. FINDINGS 1802 participants responded in the adolescent phase, with 149 (8%) reporting self-harm, More girls (95/947 [10%]) than boys (54/855 [6%]) reported self-harm (risk ratio 1·6, 95% CI 1·2-2·2). We recorded a substantial reduction in the frequency of self-harm during late adolescence. 122 of 1652 (7%) participants who reported self-harm during adolescence reported no further self-harm in young adulthood, with a stronger continuity in girls (13/888) than boys (1/764). During adolescence, incident self-harm was independently associated with symptoms of depression and anxiety (HR 3·7, 95% CI 2·4-5·9), antisocial behaviour (1·9, 1·1-3·4), high-risk alcohol use (2·1, 1·2-3·7), cannabis use (2·4, 1·4-4·4), and cigarette smoking (1·8, 1·0-3·1). Adolescent symptoms of depression and anxiety were clearly associated with incident self-harm in young adulthood (5·9, 2·2-16). INTERPRETATION Most self-harming behaviour in adolescents resolves spontaneously. The early detection and treatment of common mental disorders during adolescence might constitute an important and hitherto unrecognised component of suicide prevention in young adults. FUNDING National Health and Medical Research Council, Australia, and operational infrastructure support programme, Government of Victoria, Australia.


The Lancet | 2014

The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study

George C Patton; Carolyn Coffey; Helena Romaniuk; Andrew Mackinnon; John B. Carlin; Louisa Degenhardt; Craig A. Olsson; Paul Moran

BACKGROUND Most adults with common mental disorders report their first symptoms before 24 years of age. Although adolescent anxiety and depression are frequent, little clarity exists about which syndromes persist into adulthood or resolve before then. In this report, we aim to describe the patterns and predictors of persistence into adulthood. METHODS We recruited a stratified, random sample of 1943 adolescents from 44 secondary schools across the state of Victoria, Australia. Between August, 1992, and January, 2008, we assessed common mental disorder at five points in adolescence and three in young adulthood, commencing at a mean age of 15.5 years and ending at a mean age of 29.1 years. Adolescent disorders were defined on the Revised Clinical Interview Schedule (CIS-R) at five adolescent measurement points, with a primary cutoff score of 12 or higher representing a level at which a family doctor would be concerned. Secondary analyses addressed more severe disorders at a cutoff of 18 or higher. FINDINGS 236 of 821 (29%; 95% CI 25-32) male participants and 498 of 929 (54%; 51-57) female participants reported high symptoms on the CIS-R (≥12) at least once during adolescence. Almost 60% (434/734) went on to report a further episode as a young adult. However, for adolescents with one episode of less than 6 months duration, just over half had no further common mental health disorder as a young adult. Longer duration of mental health disorders in adolescence was the strongest predictor of clear-cut young adult disorder (odds ratio [OR] for persistent young adult disorder vs none 3.16, 95% CI 1.86-5.37). Girls (2.12, 1.29-3.48) and adolescents with a background of parental separation or divorce (1.62, 1.03-2.53) also had a greater likelihood of having ongoing disorder into young adulthood than did those without such a background. Rates of adolescent onset disorder dropped sharply by the late 20s (0.57, 0.45-0.73), suggesting a further resolution for many patients whose symptoms had persisted into the early 20s. INTERPRETATION Episodes of adolescent mental disorder often precede mental disorders in young adults. However, many such disorders, especially when brief in duration, are limited to the teenage years, with further symptom remission common in the late 20s. The resolution of many adolescent disorders gives reason for optimism that interventions that shorten the duration of episodes could prevent much morbidity later in life. FUNDING Australias National Health and Medical Research Council.


The Lancet | 2011

50-year mortality trends in children and young people: a study of 50 low-income, middle-income, and high-income countries

Russell M. Viner; Carolyn Coffey; Colin Mathers; Paul Bloem; Anthony Costello; John S. Santelli; George C Patton

BACKGROUND Global attention has focused on mortality in children younger than 5 years. We analysed global mortality data for people aged 1-24 years across a 50-year period. METHODS The WHO mortality database was used to obtain mortality data from 1955 to 2004, by age-group (1-4, 5-9, 10-14, 15-19, and 20-24 years) and stratified by sex. To analyse change in mortality, we calculated mortality rates averaged over three 5-year periods (1955-59, 1978-82, and 2000-04) to investigate trends in deaths caused by communicable and non-communicable diseases and injury. FINDINGS Data were available for 50 countries (ten high income, 22 middle income, eight low income, seven very low income, and three unclassified), grouped as Organisation for Economic Co-operation and Development (OECD) countries, Central and South American countries, eastern European countries and ex-Soviet states, and other countries. In 1955, mortality was highest in the 1-4-year age-group. Across the study period, all-cause mortality reduced by 85-93% in children aged 1-4 years, 80-87% in children aged 5-9 years, and 68-78% in young people aged 10-14 years in OECD, Central and South American, and other countries. Smaller declines (41-48%) were recorded in young men (15-24 years), and by 2000-04, mortality in this group was two-to-three times higher than that in young boys (1-4 years). Mortality in young women (15-24 years) was equal to that of young girls (1-4 years) from 2000 onwards. Substantial declines in death caused by communicable diseases were seen in all age-groups and regions, although communicable and non-communicable diseases remained the main causes of death in children (1-9 years) and young women (10-24 years). Injury was the dominant cause of death in young men (10-24 years) in all regions by the late 1970s. INTERPRETATION Adolescents and young adults have benefited from the epidemiological transition less than children have, with a reversal of traditional mortality patterns over the past 50 years. Future global health targets should include a focus on the health problems of people aged 10-24 years. FUNDING None.


Drug and Alcohol Dependence | 2010

Cannabis use and educational achievement: Findings from three Australasian cohort studies

L. John Horwood; David M. Fergusson; Mohammad R. Hayatbakhsh; Jake M. Najman; Carolyn Coffey; George C Patton; Edmund Silins; Delyse Hutchinson

BACKGROUND The associations between age of onset of cannabis use and educational achievement were examined using data from three Australasian cohort studies involving over 6000 participants. The research aims were to compare findings across studies and obtain pooled estimates of association using meta-analytic methods. METHODS Data on age of onset of cannabis use (<15, 15-17, never before age 18) and three educational outcomes (high school completion, university enrolment, degree attainment) were common to all studies. Each study also assessed a broad range of confounding factors. RESULTS There were significant (p<.001) associations between age of onset of cannabis use and all outcomes such that rates of attainment were highest for those who had not used cannabis by age 18 and lowest for those who first used cannabis before age 15. These findings were evident for each study and for the pooled data, and persisted after control for confounding. There was no consistent trend for cannabis use to have greater effect on the academic achievement of males but there was a significant gender by age of onset interaction for university enrolment. This interaction suggested that cannabis use by males had a greater detrimental effect on university participation than for females. Pooled estimates suggested that early use of cannabis may contribute up to 17% of the rate of failure to obtain the educational milestones of high school completion, university enrolment and degree attainment. CONCLUSIONS Findings suggest the presence of a robust association between age of onset of cannabis use and subsequent educational achievement.


Addiction | 2013

The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood

Louisa Degenhardt; Carolyn Coffey; Helena Romaniuk; Wendy Swift; John B. Carlin; Wayne Hall; George C Patton

AIMS Debate continues about whether the association between cannabis use in adolescence and common mental disorders is causal. Most reports have focused on associations in adolescence, with few studies extending into adulthood. We examine the association from adolescence until the age of 29 years in a representative prospective cohort of young Australians. DESIGN Nine-wave, 15-year representative longitudinal cohort study, with six waves of data collection in adolescence (mean age 14.9-17.4 years) and three in young adulthood (mean age 20.7, 24.1 and 29.1 years). PARTICIPANTS Participants were a cohort of 1943 recruited in secondary school and surveyed at each wave when possible from mid-teen age to their late 20s. SETTING Victoria, Australia. MEASUREMENTS Psychiatric morbidity was assessed with the Revised Clinical Interview Schedule (CIS-R) at each adolescent wave, and as Composite International Diagnostic Interview (CIDI)-defined ICD-10 major depressive episode and anxiety disorder at 29 years. Frequency of cannabis use was measured in the past 6 months in adolescence. Cannabis use frequency in the last year and DSM-IV cannabis dependence were assessed at 29 years. Cross-sectional and prospective associations of these outcomes with cannabis use and dependence were estimated as odds ratios (OR), using multivariable logistic regression models, with the outcomes of interest, major depressive episode (MDE) and anxiety disorder (AD) at 29 years. FINDINGS There were no consistent associations between adolescent cannabis use and depression at age 29 years. Daily cannabis use was associated with anxiety disorder at 29 years [adjusted OR 2.5, 95% confidence interval (CI):< 1.2-5.2], as was cannabis dependence (adjusted OR 2.2, 95% CI: 1.1-4.4). Among weekly+ adolescent cannabis users, those who continued to use cannabis use daily at 29 years remained at significantly increased odds of anxiety disorder (adjusted OR 3.2, 95% CI: 1.1-9.2). CONCLUSIONS Regular (particularly daily) adolescent cannabis use is associated consistently with anxiety, but not depressive disorder, in adolescence and late young adulthood, even among regular users who then cease using the drug. It is possible that early cannabis exposure causes enduring mental health risks in the general cannabis-using adolescent population.


Addiction | 2008

Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood

Wendy Swift; Carolyn Coffey; John B. Carlin; Louisa Degenhardt; George C Patton

AIMS To examine the association between cannabis use by 18 years and problematic cannabis use at 24 years, considering possible mediating and confounding factors. DESIGN Ten-year representative prospective study with data from six time-points in adolescence (mean age 14.9-17.4 years) and two in young adulthood (mean age 20.7 and 24.1 years) SETTING Victoria, Australia. PARTICIPANTS Inception cohort of 1943 secondary school students (95.6% response rate), with 1520 (78% of adolescent participants) interviewed in the final wave. MEASUREMENTS Participants reported frequency of cannabis use for the past 6 months at each time-point in adolescence (age 14-17 years). Cannabis exposure was defined as: maximum frequency of use (occasional, weekly, daily), number of waves of use (1 or 2; 3-6) and first wave of use (early use: first waves 1-3). Young adult (24 years) outcomes were: weekly+ cannabis use and DSM-IV cannabis dependence, referred to collectively as problematic use. FINDINGS Of those interviewed at age 24 (wave 8), 34% had reported cannabis use in adolescence (waves 1-6), 12% at a level of weekly or more frequent use; 37% of these adolescent cannabis users were using at least weekly at wave 8, with 20% exhibiting dependence. Persistent adolescent cannabis and tobacco use as well as persistent mental health problems were associated strongly with problematic cannabis use at 24 years, after adjustment for potential confounding factors. CONCLUSIONS Heavy, persistent and early-onset cannabis use were all strongly predictive of later cannabis problems. Even so, occasional use was not free of later problems. Where there was co-occurring tobacco use or persistent mental health problems, risks for later problem cannabis use was higher.

Collaboration


Dive into the Carolyn Coffey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Louisa Degenhardt

National Drug and Alcohol Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wendy Swift

National Drug and Alcohol Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wayne Hall

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge